Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest ROA

Below are the top diagnostic substances stocks on the NASDAQ in terms of return on assets. The trailing-twelve-month return on assets at Meridian Bioscience VIVO is 21.50%. Meridian Bioscience's revenue for the same period is $188.10 million. The trailing-twelve-month return on assets at IDEXX Laboratories IDXX is 19.70%. IDEXX Laboratories' operating margin for the same period is 19.40%. The trailing-twelve-month return on assets at Neogen NEOG is 15.90%. Neogen's EPS for the same period is $0.75. The trailing-twelve-month return on assets at SurModics SRDX is 14.30%. SurModics' PEG ratio is 1.57.